Quest Diagnostics 

$152.13
173
-$2.73-1.76% 今天

统计数据

当日最高
155.09
当日最低
151.79
52周最高
159.36
52周最低
120.1
成交量
529,044
平均成交量
821,603
市值
17.47B
市盈率
21.18
股息收益率
1.97%
股息
3

即将到来

股息

1.97%股息收益率
10年增长
8.66%
5年增长
6.9%
3年增长
6.94%
1年增长
6.09%

收益

22Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
1.86
2.02
2.19
2.35
预期每股收益
2.280225
实际每股收益
N/A

人们还关注

此列表基于关注DGX的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

155.78$平均价格目标
最高估值为 $165。
来自过去6个月内的 9 个评级。这不是投资建议。
买入
22%
持有
78%
卖出
0%

关于

Health Services
Services to the Health Industry
Manufacturing
Dental Laboratories
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Show more...
首席执行官
Stephen Rusckowski
员工
50000
国家
US
ISIN
US74834L1008

上市公司